Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Intracellular space

Hypokalemia is a reduction of plasma K+ concentration below 3.5 mM. Hypokalemia can result from a reduction in dietary K+ intake and from a shift of K into the intracellular space. The most common of hypokalemia, however, is renal K+ loss (i.e., caused by diuretics). [Pg.609]

Patients with acute hyperkalemia usually require other therapies to manage hyperkalemia until dialysis can be initiated. Patients who present with cardiac abnormalities caused by hyperkalemia should receive calcium gluconate or chloride (1 g intravenously) to reverse the cardiac effects. Temporary measures can be employed to shift extracellular potassium into the intracellular compartment to stabilize cellular membrane effects of excessive serum potassium levels. Such measures include the use of regular insulin (5 to 10 units intravenously) and dextrose (5% to 50% intravenously), or nebulized albuterol (10 to 20 mg). Sodium bicarbonate should not be used to shift extracellular potassium intracellularly in patients with CKD unless severe metabolic acidosis (pH less than 7.2) is present. These measures will decrease serum potassium levels within 30 to 60 minutes after treatment, but potassium must still be removed from the body. Shifting potassium to the intracellular compartment, however, decreases potassium removal by dialysis. Often, multiple dialysis sessions are required to remove potassium that is redistributed from the intracellular space back into the serum. [Pg.382]

Hyperkalemia is defined as a serum potassium concentration greater than 5 mEq/L (5 mmol/L). Manifestations of hyperkalemia include muscle weakness, paresthesias, hypotension, ECG changes (e.g., peaked T waves, shortened QT intervals, and wide QRS complexes), cardiac arrhythmias, and a decreased pH. Causes of hyperkalemia fall into three broad categories (1) increased potassium intake (2) decreased potassium excretion and (3) potassium release from the intracellular space. [Pg.412]

Dextrose and insulin (with or without sodium bicarbonate) are typically given at the time of calcium therapy in order to redistribute potassium into the intracellular space. Dextrose 50% (25 g in 50 mL) can be given by slow IV push over 5 minutes or dextrose 10% with 20 units of regular insulin can be given by continuous TV infusion over 1 to 2 hours. The onset of action for this combination is 30 minutes and the duration of clinical effects... [Pg.412]

Intracellular space Fibrous protein ( 65-70%), nonfibrous (soluble) protein ( 5-10%) 75... [Pg.196]

K+ ion from the intracellular space would bind to site 1. In this way, the pore remains occupied by two ions, during steady outward conduction. [Pg.105]

This solution will result in osmotic removal of water from the intracellular space. [Pg.895]

During the process, the solute diffuses into the intercellular space and, depending on the characteristics of the solute, it may pass through the membrane and enter the intracellular space. Differences in chemical potentials of water and solutes in the system result in fluxes of several components of the material and solution water drain and solute uptake are the two main simultaneous flows. Together with the changes in chemical composition of the food material, structural changes such as shrinkage, porosity reduction, and cell collapse take place and influence mass transfer behavior in the tissue. [Pg.186]

A very important factor in ensuring that full cell wall penetration has occurred is to allow sufficient time for the impregnant molecules to diffuse into the intracellular spaces. Many workers allow several days (weeks in some cases) for this to occur. It is important to emphasize that pressure treatment will aid penetration of larger wood samples, but will not in any way result in cell wall penetration, which is a purely diffusion-controlled process. [Pg.150]

In humans, for all these compounds, Vp is about 0.15-0.27 L kg (consistent with the extracellular volume which, in humans, is about 0.25 L kg ), Tj/ja is 4- 10min,Ti/2 is between 100 and 130 min and total clearance is 1-2 mLmin kg [5]. These compounds are characterized by a rapid distribution about 70% of the injected dose is cleared from plasma (diffusion and excretion) within 2-5 minutes after injection [5]. Because of their high hydrophilicity, they do not enter the intracellular space to a significant extent. [Pg.153]

Following its uptake into the body, the drug is distributed in the blood (1) and through it to the various tissues of the body. Distribution may be restricted to the extracellular space (plasma volume plus interstitial space) (2) or may also extend into the intracellular space (3). Certain drugs may bind strongly to tissue structures, so that plasma concentrations fall significantly even before elimination has begun (4). [Pg.28]

Homeostasis. The blood ensures that a balanced distribution of water is maintained between the vascular system, the cells (intracellular space), and the extracellular space. The acid-base balance is regulated by the blood in combination with the lungs, liver, and kidneys (see p. 288). The regulation of body temperature also depends on the controlled transport of heat by the blood. [Pg.274]

Pfiarmacokinetics Time to peak after IM administration occurs in 30-60 min. Widely distributed to all tissues including the brain and, mainly, intracellular space. Rapidly metabolized by the liver to inactive metabolites. Excreted in the urine and bile. Removed by hemodialysis. Half-life 4 hr. [Pg.378]

The better correlation with in vitro data obtained from hepatocytes (relative to microsomes) deserves further investigation. This difference may be due to a difference in catalytic activity in vivo relative to optimal conditions in vitro. It is possible that use of non-physiological buffer conditions will overstate or understate the contribution of a particular P450 to overall metabolism. For example, the role of cytochrome bs/OR in catalytic activity is influenced by ionic strength (Schenkman et al., 1994 Voznesensky and Schenkman, 1994) which is a variable in microsmal incubations but not in the intracellular space of a hepatocyte. This suggests that performing incubations of cDNA-expressed enzymes under conditions which mimic intact cells may substantially improve correlations. [Pg.196]


See other pages where Intracellular space is mentioned: [Pg.359]    [Pg.105]    [Pg.1267]    [Pg.195]    [Pg.7]    [Pg.27]    [Pg.412]    [Pg.413]    [Pg.196]    [Pg.218]    [Pg.473]    [Pg.395]    [Pg.227]    [Pg.165]    [Pg.332]    [Pg.335]    [Pg.6]    [Pg.168]    [Pg.253]    [Pg.186]    [Pg.249]    [Pg.251]    [Pg.29]    [Pg.173]    [Pg.16]    [Pg.7]    [Pg.610]    [Pg.20]    [Pg.23]    [Pg.442]    [Pg.415]    [Pg.41]    [Pg.244]    [Pg.215]    [Pg.563]    [Pg.786]    [Pg.359]   
See also in sourсe #XX -- [ Pg.6 , Pg.168 ]

See also in sourсe #XX -- [ Pg.53 , Pg.54 , Pg.118 , Pg.119 ]

See also in sourсe #XX -- [ Pg.361 ]




SEARCH



© 2024 chempedia.info